American Medical Systems Europe B.V., founded in the Netherlands, operates as a provider of innovative medical technologies focusing on solutions for urology and pelvic health. The company offers a range of products, including surgical devices and therapies aimed at improving the quality of life for patients with specific medical conditions.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| BSX 0.75% 2025-03-08 EURAmerican Medical Systems Europe B.V. | Netherlands | 2025-03-08 | 0.750 | 0.00 |
| BSX 1.38% 2028-03-08 EURAmerican Medical Systems Europe B.V. | Ireland | 2028-03-08 | 1.375 | 2.48 |
| BSX 1.63% 2031-03-08 EURAmerican Medical Systems Europe B.V. | Ireland | 2031-03-08 | 1.625 | 2.99 |
| BSX 1.88% 2034-03-08 EURAmerican Medical Systems Europe B.V. | Ireland | 2034-03-08 | 1.875 | 3.35 |
| BSX 3.00% 2031-03-08 EURAmerican Medical Systems Europe B.V. | Ireland | 2031-03-08 | 3.000 | 3.00 |
| BSX 3.25% 2034-03-08 EURAmerican Medical Systems Europe B.V. | Ireland | 2034-03-08 | 3.250 | 3.39 |
| BSX 3.38% 2029-03-08 EURAmerican Medical Systems Europe B.V. | Ireland | 2029-03-08 | 3.375 | 2.69 |
| BSX 3.50% 2032-03-08 EURAmerican Medical Systems Europe B.V. | Ireland | 2032-03-08 | 3.500 | 3.13 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Since its first bond issuance in 2010, American Medical Systems has strategically utilized the capital markets to finance its growth initiatives. Notable bond offerings include a €250 million issuance in 2015, which was utilized to enhance product development capabilities. Currently, the company's bonds yield approximately 4.5%, aligning well with industry averages, while its bonds feature a blend of fixed and variable interest rates, catering to a diverse investor base. Recent news also highlights the company's commitment to sustainability, as it plans to issue green bonds to support environmentally-focused projects.